Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.730
-0.010 (-0.36%)
At close: Sep 11, 2026, 4:00 PM EDT
2.779
+0.049 (1.81%)
After-hours: Sep 11, 2026, 7:58 PM EDT
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $462.86 million as of September 11, 2026. Its market cap has increased by 190.83% in one year.
Market Cap
462.86M
Enterprise Value
263.47M
1-Year Change
190.83%
Ranking
Category
Stock Price
$2.73
ChartMarket Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $462.86M, an increase of 96.52%. That is a compound annual growth rate of 10.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 462.86M | 119.55% |
| Dec 31, 2025 | 210.82M | 90.01% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eikon Therapeutics | 498.86M |
| Entera Bio | 483.07M |
| Capricor Therapeutics | 482.55M |
| Prelude Therapeutics | 480.99M |
| Puma Biotechnology | 473.36M |
| Prothena Corporation | 463.06M |
| Ginkgo Bioworks Holdings | 456.57M |
| Kyverna Therapeutics | 454.55M |